Cancer breakthrough: New diagnostic tool could spot cancer missed in 3/4 of early cases
OVARIAN cancer is difficult to detect and diagnose, with fewer than half of all women surviving the five year mark after being diagnosed. A new technology may solve the issue of diagnosis. (Source: Daily Express - Health)
Source: Daily Express - Health - January 22, 2022 Category: Consumer Health News Source Type: news

Tennis Star Chris Evert Teaches Us That Genetic Testing Is A Lifetime Match
Chris Evert's sister died of ovarian cancer in 2020. Her genetic test results did not reveal a mutation — but that changed, saving Chris' life. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 17, 2022 Category: Pharmaceuticals Authors: Ellen Matloff, Contributor Tags: Healthcare /healthcare Innovation /innovation Business /business SportsMoney /sportsmoney pharma & Source Type: news

BRCA Testing Underused in Women With Ovarian Cancer BRCA Testing Underused in Women With Ovarian Cancer
More than a decade after calls for universal screening for germline BRCA mutations in women with ovarian cancer, it remains underused.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 14, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Symptoms Common in High-Risk, Early-Stage Ovarian Cancer Symptoms Common in High-Risk, Early-Stage Ovarian Cancer
"Even in early-stage disease, ovarian cancer is not necessarily a silent disease."Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - January 13, 2022 Category: Internal Medicine Tags: Ob/Gyn & Women ' s Health News Source Type: news

NCI Opens New Immunotherapy Clinical Trial for Mesothelioma
This study offers a reasonable chance of benefit. It would be nice to see if these patients again respond to immunotherapy.” The FDA approved Opdivo and Yervoy, an immunotherapy combination, for first-line treatment of pleural mesothelioma in 2020. It was the first new systemic approval in more than 16 years. However, it only increased the median overall survival time from 14.1 months to 18.1 months, when compared to standard chemotherapy. Find Immunotherapy Clinical Trials Learn how to access mesothelioma clinical trial...
Source: Asbestos and Mesothelioma News - January 4, 2022 Category: Environmental Health Authors: Chris Elkins Source Type: news

Ovarian cancer symptoms: Why 'silent killer' isn't so silent - 5 signs to get checked
OVARIAN CANCER is notoriously difficult to diagnose early with many women finding out when it is simply too late. But what are the key symptoms to look out for in order to spot this disease before it spreads? (Source: Daily Express - Health)
Source: Daily Express - Health - December 31, 2021 Category: Consumer Health News Source Type: news

New Clues to How Ovarian Cancer Begins — and Might Be Prevented
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 29, 2021 Category: Cancer & Oncology Tags: Gynecology, Oncology, Research, News, Source Type: news

New Clues to How Ovarian Cancer Begins -- and Might Be Prevented
WEDNESDAY, Dec. 29, 2021 -- Researchers say they may be closer than ever to detecting ovarian cancer earlier and improving the odds for women with this life-threatening disease. In a new study, scientists used stem cells created from the blood... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 29, 2021 Category: General Medicine Source Type: news

'Jolie gene' test could help women avoid needless cancer operations
A breakthrough could help thousands of women with the 'Jolie gene' to delay or avoid cancer surgery and allow doctors to predict when and if patients with a faulty gene develop breast and ovarian cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - December 29, 2021 Category: Consumer Health News Source Type: news

New Clues to How Ovarian Cancer Begins
Title: New Clues to How Ovarian Cancer BeginsCategory: Health NewsCreated: 12/29/2021 12:00:00 AMLast Editorial Review: 12/29/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - December 29, 2021 Category: Cancer & Oncology Source Type: news

Study reveals how ovarian cancer develops in high-risk women
Researchers at Cedars-Sinai Medical Center in Los Angeles believe they have learned how a genetic mutation places some women at high risk for ovarian cancer, according to an article published by the journal Cell Reports. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 28, 2021 Category: Consumer Health News Source Type: news

Ovarian cancer symptoms: When your stomach pain is something serious - key signs explained
OVARIAN CANCER symptoms are often dismissed as side effects of irritable bowel syndrome and other less serious illnesses - but what are the differences to look out for? (Source: Daily Express - Health)
Source: Daily Express - Health - December 21, 2021 Category: Consumer Health News Source Type: news

Lab Notes: Penn plays role in new cancer imaging agent; Carisma names new chairman
The newly approved imaging agent is designed to allow for the earlier detection of ovarian cancer. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 3, 2021 Category: Pharmaceuticals Authors: John George Source Type: news

FDA approves pafolacianine for identifying malignant ovarian cancer lesions
Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 1, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Olaparib cost effective for in BRCA-mutated advanced ovarian carcinoma in Spain
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 1, 2021 Category: Drugs & Pharmacology Source Type: news

FDA Approves Imaging Drug That Helps Spot Ovarian Cancers
Title: FDA Approves Imaging Drug That Helps Spot Ovarian CancersCategory: Health NewsCreated: 11/29/2021 12:00:00 AMLast Editorial Review: 11/30/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 30, 2021 Category: Cancer & Oncology Source Type: news

FDA Approves Cytalux (pafolacianine) Injection for Identification of Ovarian Cancer During Surgery
WEST LAFAYETTE, Ind., Nov. 29, 2021 /PRNewswire/ -- On Target Laboratories, Inc., a privately-held biotechnology company developing fluorescent imaging agents to target and illuminate cancer during surgery, today announced that the U.S. Food and... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 29, 2021 Category: Drugs & Pharmacology Source Type: news

FDA Approves Imaging Drug for Detecting Ovarian Cancer Lesions FDA Approves Imaging Drug for Detecting Ovarian Cancer Lesions
The tumor-targeted agent pafolacianine causes ovarian cancer lesions to'light up like stars against a night sky'and improve surgeons'ability to locate cancerous tissue.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 29, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Maintenance Olaparib Benefits Sustained Beyond 2 Years Treatment Maintenance Olaparib Benefits Sustained Beyond 2 Years Treatment
Women with newly diagnosed ovarian cancer and a BRCA mutation see sustained benefits in progression free survival rates after two years of maintenance olaparib therapy, a clinical trial analysis suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 25, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Gather your family health history this Thanksgiving; it could save your life
Thanksgiving Day marks Family Health History Day, an annual national public health campaign to encourage people to better understand what health characteristics run in their families. Has your mother, sister or grandmother had breast or ovarian cancer? Has your father had prostate cancer? Is there a history of colon cancer, diabetes, or high cholesterol in your family?  If so, you also could be at risk. John Presutti, D.O., a Mayo Clinic family medicine physician, says don't… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 22, 2021 Category: Databases & Libraries Source Type: news

Ovarian transplant technique extends fertility in cancer patients
In a Q&A, Yale ’s Kutluk Oktay shares his new approach to transplanting cryopreserved ovarian tissue and what it means for those undergoing cancer treatment. (Source: Yale Science and Health News)
Source: Yale Science and Health News - November 17, 2021 Category: Universities & Medical Training Source Type: news

Johnson & Johnson Will Split Into Two Companies, Aiming for Faster Growth
Johnson & Johnson is peeling off a consumer health business that helped it become the world’s biggest health care products maker. The company said Friday that it will separate its segment that sells Band-Aids, Listerine and over-the-counter medicines like Tylenol from its pharmaceutical and medical device business. Company leaders told analysts that the split into two publicly traded companies will make each business more nimble in adapting to their respective markets. It also allows for a more precise allocation of capital. CEO Alex Gorsky said that while the company’s broad focus has worked in the past, t...
Source: TIME: Health - November 12, 2021 Category: Consumer Health News Authors: MICHELLE CHAPMAN and TOM MURPHY / AP Tags: Uncategorized Companies wire Source Type: news

Court Deals Blow to Johnson & Johnson Bankruptcy Plan for Talc Cases
A federal judge in North Carolina delivered a major setback to Johnson & Johnson and its controversial plan to unload all talc-related litigation in bankruptcy court through a recently-created subsidiary. Bankruptcy Judge Craig Whitley said he was “obligated” to move the case from North Carolina to New Jersey, where Johnson & Johnson is headquartered and thousands of the talc-related lawsuits are already pending. The move from North Carolina to New Jersey takes J&J from a jurisdiction considered favorable to its bankruptcy strategy to one that is unfavorable, based upon past cases. Johnson ...
Source: Asbestos and Mesothelioma News - November 12, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Ovarian cancer patients given fresh hope thanks to double drug treatment
Ruth Joy (pictured), from West Sussex, was diagnosed with advanced, slow-growing ovarian cancer in 2006. She has benefitted from a clinical trial involving MEK inhibitors and defactinib. (Source: the Mail online | Health)
Source: the Mail online | Health - November 6, 2021 Category: Consumer Health News Source Type: news

Cyclophosphamide-Free Adjuvant Chemo for Ovarian Protection Cyclophosphamide-Free Adjuvant Chemo for Ovarian Protection
Could this chemotherapy regimen help preserve fertility among young women being treated for breast cancer?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 1, 2021 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Nadia Chaudhri, Scientist With an End-of-Life Mission, Dies at 43
She documented her last months with ovarian cancer on Twitter while raising funds to support students from backgrounds that are underrepresented in the sciences. (Source: NYT Health)
Source: NYT Health - October 20, 2021 Category: Consumer Health News Authors: Annabelle Williams Tags: Colleges and Universities Philanthropy Ovarian Cancer Deaths (Obituaries) Social Media Chaudhri, Nadia (1978-2021) Research Concordia University (Montreal) Source Type: news

Johnson & Johnson Sending Talc Cases to Bankruptcy Court
As expected, Johnson & Johnson has unloaded its burgeoning talc-related liabilities on a new subsidiary that filed for Chapter 11 bankruptcy protection on Oct. 14. The controversial move, which confirmed the fears of many personal injury attorneys, is an attempt by J&J to more easily resolve the thousands of current and future lawsuits claiming that its talc products have caused serious medical problems, including ovarian and mesothelioma cancers. Most of the claims contend that talc in the products was contaminated with toxic asbestos fibers. The filing, in U.S. Bankruptcy Court in the Western District of...
Source: Asbestos and Mesothelioma News - October 18, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Johnson & Johnson Takes Steps to Equitably Resolve All Current and Future Talc Claims
NEW BRUNSWICK, N.J., October 14, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that LTL Management LLC (LTL), a newly created and separate subsidiary of Johnson & Johnson, that was established to hold and manage claims in the cosmetic talc litigation, has filed for voluntary Chapter 11 bankruptcy protection. This filing is intended to resolve all claims related to cosmetic talc in a manner that is equitable to all parties, including any current and future claimants. Johnson & Johnson and its other affiliates did not file for bankruptcy protection and will continue to operate their bus...
Source: Johnson and Johnson - October 14, 2021 Category: Pharmaceuticals Tags: Latest News Source Type: news

Why a One-Size-Fits-All Approach to Breast Cancer Prevention Can Leave Women Vulnerable
When Heather Mann learned she had breast cancer, it was a complete surprise. “I had never thought that I was at high risk for breast cancer,” the 49-year-old says. “I don’t have any family lineage or history of breast cancer. My grandmother on my father’s side had breast cancer, but apparently that’s not usually a significant factor. So I was very surprised when I found out that I had a malignant tumor.” Shelia Bauer ‘s breast cancer journey took a very different route. After her twin sisters died of the disease in their 50s, Bauer, now 73, assumed that she likely carried som...
Source: TIME: Health - October 13, 2021 Category: Consumer Health News Authors: Time Tags: Uncategorized Cancer healthscienceclimate Source Type: news

Penn State team secures funding to develop wearable brain scanner
Researchers from Pennsylvania State University have been awarded a two-year...Read more on AuntMinnie.comRelated Reading: Photoacoustic US shows promise for visualizing lymphatic vessels Ultrasound + photoacoustic imaging spot prostate cancer New imaging method could boost ovarian cancer detection Group reveals work on hybrid acoustic-optical imaging Photoacoustic US offers option to thyroid biopsy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 12, 2021 Category: Radiology Source Type: news

Twitter mourns educator Dr. Nadia Chaudhri. What can be learned from her story?
Dr. Nadia Chaudhri, a neuroscientist and professor, shared her experience with ovarian cancer on Twitter, showing how social media can be a powerful tool to connect and educate on chronic or serious illnesses. (Source: mobihealthnews)
Source: mobihealthnews - October 11, 2021 Category: Information Technology Source Type: news

Unexpected Thrombocytosis Could Flag Occult Cancer Unexpected Thrombocytosis Could Flag Occult Cancer
Thrombocytosis that shows up in a routine blood test increases the risk for an imminent diagnosis of several typically'silent'cancers, such as pancreatic, ovarian, and cervical cancers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 4, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Ovarian cancer: The common pattern when peeing that can be a sign - what to look for
OVARIAN cancer symptoms can sometimes be hard to spot, and might be confused for other conditions. It is important to be aware of the signs, as the earlier ovarian cancer is diagnosed and treated, the better the chance of a cure. (Source: Daily Express - Health)
Source: Daily Express - Health - October 2, 2021 Category: Consumer Health News Source Type: news

‘Highly effective’ ovarian cancer treatment could help thousands of women
New drug combination shrunk tumours significantly in 46% of patients with treatment-resistant form of diseaseThousands of women withovarian cancer could benefit from a revolutionary drug combination after it was shown to shrink tumours in half of patients with an advanced form of the disease.The pair of drugs – which work together to block the signals cancer cells need to grow – could offer a new treatment option for women with a type of ovarian cancer that rarely responds to chemotherapy or hormone therapy.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 19, 2021 Category: Science Authors: Andrew Gregory Health editor Tags: Ovarian cancer Breast cancer Medical research Health Society Science Source Type: news

Cell therapy partnership between Bay Area biotechs offers hope to cancer patients
Imagine a world in which physicians can confidently cure cancer. Two Bay Area life sciences companies are working together to make this vision a reality. Atara Biotherapeutics Inc., founded in 2012, is developing a pipeline of cell therapies to treat various types of cancer and autoimmune diseases. Bayer is licensing Atara’s cutting-edge cell therapies that t arget certain types of aggressive tumors including mesothelioma, pancreatic, ovarian and non-small-cell lung cancer. “With cancer therapies,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 16, 2021 Category: Pharmaceuticals Authors: Lauren Lawley Head Source Type: news

Cancer symptoms: Seven signs of ovarian cancer - a cancer difficult to diagnose early
BEING the fifth leading cause of cancer death in women, targeting the early signs of ovarian cancer is vital in order to prevent the spread of the disease. However, this particular form of cancer has proven difficult for doctors to diagnose before it is too late. (Source: Daily Express - Health)
Source: Daily Express - Health - September 13, 2021 Category: Consumer Health News Source Type: news

Janssen Demonstrates Commitment to Advancing Science and Innovation in the Treatment of Solid Tumors at ESMO Annual Congress
September 8, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than ten data presentations from its lung cancer, bladder cancer and prostate cancer portfolio and pipeline will be featured during the European Society for Medical Oncology (ESMO) Annual Congress 2021 virtual meeting, September 16–21. Further details about these data and the science Janssen is advancing will be made available throughout ESMO via the Janssen Oncology Virtual Newsroom.“With a diverse oncology portfolio and pipeline spanning bladder cancer, lung cancer and prostate can...
Source: Johnson and Johnson - September 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Consumer Health: Treating ovarian cancer
September is Ovarian Cancer Awareness Month, which makes this a good time to learn about treating ovarian cancer. Ovarian cancer ranks fifth in cancer deaths among women in the U.S., according to the American Cancer Society. More than 21,000 new cases will be diagnosed in the U.S. this year, and nearly 14,000 women will die of the disease. Early stage ovarian cancer rarely causes any symptoms. Advanced-stage ovarian cancer may cause few and nonspecific symptoms… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 1, 2021 Category: Databases & Libraries Source Type: news

Judge Moves Johnson & Johnson Closer to Potential Reorganization
Johnson & Johnson is closer to unloading its talc-related liabilities onto a new subsidiary that could subsequently declare Chapter 11 bankruptcy and dramatically alter the thousands of lawsuits the company is facing. A U.S. Bankruptcy Court judge in the District of Delaware declined requests last week from a panel of personal injury lawyers to prohibit Johnson & Johnson from exercising that option. J&J is facing more than 34,000 lawsuits that link its talc-based products to cancer, the majority of which are ovarian cancer. A small fraction of those lawsuits involve malignant mesothelioma. Most of the ...
Source: Asbestos and Mesothelioma News - August 31, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Roundup: ANDHealth receives $14M in gov't funding, Zhongchao launches ovarian cancer patient management platform and more briefs
Also, digital health firms in Myanmar and the Philippines are offering free virtual doctor consultations. (Source: mobihealthnews)
Source: mobihealthnews - August 27, 2021 Category: Information Technology Source Type: news

Mesothelioma Olaparib Clinical Trial Targets Genetic Mutation
The mesothelioma program at University of Chicago Medicine is recruiting patients for its latest clinical trial involving olaparib, an oral chemotherapy drug targeting cancer-driven genetic mutations. This single-center, phase II clinical trial is open to patients with either pleural mesothelioma or peritoneal mesothelioma. Olaparib, also known by the brand name Lynparza, works by repairing or controlling specific gene mutations. It is known as a protein inhibitor and has been approved by the U.S. Food and Drug Administration for use with breast and ovarian cancers. Mesothelioma, a rare malignancy caused by exposu...
Source: Asbestos and Mesothelioma News - August 24, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

This Breast Cancer Gene Is Less Well Known, but Nearly as Dangerous
PALB2 is not as well known as BRCA, but mutations of the gene can raise a woman ’s risk for breast cancer almost as much. (Source: NYT Health)
Source: NYT Health - August 17, 2021 Category: Consumer Health News Authors: Susan Berger Tags: your-feed-science Breast Cancer Genetics and Heredity Tests (Medical) Pancreatic Cancer Ovarian Cancer Women and Girls American College of Medical Genetics your-feed-healthcare Source Type: news

Nigeria: Protect Breastfeeding - Strengthening Workplace Policies for Exclusive Breastfeeding in Nigeria
[Nigeria Health Watch] Breastfeeding provides essential nutrients to newborns and infants, which translate to proper growth and development from childhood to adulthood. There are many benefits to breastfeeding for both infants and mothers. These include, a reduced risk of infections, heart disease, obesity and others, for the infant and a reduced risk of breast and ovarian cancers, heart disease, etc., for the mother. It also has future economic benefits for countries. Avoidable illnesses and deaths resulting from not breastfeed (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 12, 2021 Category: African Health Source Type: news

Using AI with CT helps predict breast cancer metastasis
Using a deep-learning algorithm with contrast-enhanced CT data is an effectiv...Read more on AuntMinnie.comRelated Reading: CT/ultrasound fusion enhances ovarian biopsies CT radiomics characterizes complex cystic renal lesions Deep learning gives a boost to CT image reconstruction CT shows manifestations of recreational drug use AI plus CT improves liver steatosis assessment (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 6, 2021 Category: Radiology Source Type: news

J & J Facing Scrutiny from Congress, Black Women ’s Organization
Plaintiff attorneys and congressional leaders have renewed their push against Johnson & Johnson and its allegedly toxic, talc-based powder products, questioning motives and demanding answers, according to various media outlets. A committee of attorneys filed a restraining order in U.S. District Court in Wilmington, Delaware, July 27, hoping to prevent J&J’s potential plan to unload its talc-related liabilities on a new subsidiary that would subsequently file for bankruptcy. The next day, the U.S. House of Representatives Committee on Oversight and Reform delivered a letter to J&J’s chief execu...
Source: Asbestos and Mesothelioma News - August 2, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Black Women ’ s Group Sues Johnson & amp; Johnson Over Baby Powder
Lawsuit claims that J&J targeted baby powder ads to Black women despite knowing it contained ingredients that could cause ovarian cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 29, 2021 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Nursing, Oncology, Pathology, Pharmacy, Institutional, Source Type: news

FDA Grants Orphan Drug Designation to Novel Mesothelioma Treatment
The U.S. Food and Drug Administration has granted orphan drug designation to ONCOFID-P for the treatment of malignant pleural mesothelioma, a step toward another potential therapy option for patients. ONCOFID-P is an innovative drug conjugate already in advanced clinical development for the treatment of invasive bladder cancer. The mesothelioma designation is based on preclinical data showing high antitumor activity in laboratory and mice models. Fidia Farmaceutici, a multinational research company based in Italy, announced the latest FDA designation, which is designed to encourage the development of novel drugs, par...
Source: Asbestos and Mesothelioma News - July 28, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

New organ-on-a-chip finds crucial interaction between blood, ovarian cancer tumors
(Texas A&M University) Researchers at Texas A&M University are pushing organ-on-a-chip devices to new levels that could change the way clinicians approach cancer treatment, particularly ovarian cancer. A team has recently submitted a patent disclosure with the Texas A&M Engineering Experiment Station. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 23, 2021 Category: Cancer & Oncology Source Type: news

Johnson & Johnson Weighs Options for Talc Liabilities
Johnson & Johnson is considering the creation of a new subsidiary to absorb its widespread asbestos liabilities, according to reports in The Wall Street Journal and other news outlets. The J&J subsidiary would then declare Chapter 11 bankruptcy, potentially saving the multinational corporation billions of dollars. Reuters News Service also reported the subsidiary possibility, citing unnamed personal injury attorneys who learned of the option while negotiating their current claims with J&J officials. A spokesperson for Johnson & Johnson would not confirm the reports.  “Johnson & J...
Source: Asbestos and Mesothelioma News - July 22, 2021 Category: Environmental Health Authors: Chris Elkins Source Type: news